Adam N. McShane

Adam N. McShane

Auto-generated profile, based on publicly available information

Adam N. McShane

Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast 1 , Belfast

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2026 in Journal of Experimental Medicine
Verified
Journal Article
Open access
MBMelibea Berzosa
Melibea Berzosa
AMAdam N. McShane
Adam N. McShane
AKAnna E. Kliszczak
Anna E. Kliszczak
AAAure Aflalo
Aure Aflalo
PNPratiti Nanda
Pratiti Nanda
DMDessislava Malinova
Dessislava Malinova
A high-affinity antibody response to both infection and vaccination critically relies on the ability of B cells to capture and process antigen for presentation to CD4+ T cells. The cellular processes from antigen recognition to full B cell activation require a finely orchestrated series of events, involving signalling and intracellular trafficking mechanisms. Here, we describe a novel regulator of B cell receptor (BCR) endocytosis and intracellular trafficking. Multidomain trafficking protein sorting-related receptor with A-type repeats (SorLA) associates with the BCR and regulates uptake of both soluble and substrate-bound antigens. SorLA deletion results in altered BCR–antigen intracellular trafficking to degradative compartments, modulating eventual antigen presentation. Crucially, this change in antigen trafficking results in a significant reduction in plasma cells and humoral responses in vivo. Given the critical importance of antigen presentation in immunity, as well as autoimmune disease and malignancy, these results identify a new cellular pathway in B cell biology with potential implications for immune regulation.